2014 Analysis of the Global Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...
November 2013
318 pages
2014 Analysis of the UK Drugs of Abuse Testing Market: Hospitals and Commercial Labs
US$ 1,960.00
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
260 pages
2014 Analysis of the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
300 pages
2014 Analysis of the Global Endocrine Function Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 327-page report from Venture Planning Group contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and ...
November 2013
327 pages
2014 Analysis of the Global Immunoprotein Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... volumes, sales forecasts, supplier shares) $5,500. This new 297-page report from Venture Planning Group contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...
November 2013
297 pages
2014 Analysis of the European Immunoprotein Diagnostic Testing Market: Hospital, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 273-page report from Venture Planning Group provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...
November 2013
273 pages
2014 Analysis of the US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 3,680.00
... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, ...
November 2013
282 pages
2014 Analysis of the European Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 6,640.00
... 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies ... , market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market ...
November 2013
335 pages
2014 Analysis of the US Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 4,320.00
... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, ...
November 2013
314 pages
2014 Analysis of the European Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 7,520.00
... 363-page report from Venture Planning Group provides analysis of the European enteric disease testing market, including emerging tests, technologies, ... . About this Report This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ...
November 2013
363 pages
2014 Analysis of the European Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
US$ 6,320.00
... 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, ... profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views ...
November 2013
318 pages
2014 Analysis of the Global Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... volumes, sales forecasts, supplier shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and ...
November 2013
313 pages
2014 Analysis of the European Therapeutic Drug Monitoring (TDM) Market : Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and ...
November 2013
291 pages
Analysis of the Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... Venture Planning Group contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging ... , such as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany ...
November 2013
320 pages
